Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dacarbazine”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT02076646
What this trial is testing

A Phase I/II Dose Escalation Study of the Tumor-targeting Human L19-IL2 Monoclonal Antibody-cytokine Fusion Protein in Combination With Dacarbazine for Patients With Metastatic Melanoma

Who this might be right for
Metastatic Melanoma Stage IV
Philogen S.p.A. 96
Testing effectiveness (Phase 2)Study completedNCT00533702
What this trial is testing

IMC-1121B (Ramucirumab) With or Without Dacarbazine in Metastatic Malignant Melanoma

Who this might be right for
Metastatic Malignant Melanoma
Eli Lilly and Company 106
Testing effectiveness (Phase 2)Study completedNCT00504504
What this trial is testing

Rituximab and ABVD for Hodgkin's Patients

Who this might be right for
Lymphoma
M.D. Anderson Cancer Center 85
Large-scale testing (Phase 3)Study completedNCT00324155
What this trial is testing

Dacarbazine and Ipilimumab vs. Dacarbazine With Placebo in Untreated Unresectable Stage III or IV Melanoma

Who this might be right for
Melanoma
Bristol-Myers Squibb 681
Testing effectiveness (Phase 2)Study completedNCT00802880
What this trial is testing

Dacarbazine for Metastatic Soft Tissue and Bone Sarcoma

Who this might be right for
Sarcoma
Washington University School of Medicine 80
Testing effectiveness (Phase 2)Ended earlyNCT00496223
What this trial is testing

A Phase I/II Study of Sunitinib and Dacarbazine

Who this might be right for
Melanoma
H. Lee Moffitt Cancer Center and Research Institute 11
Early research (Phase 1)Study completedNCT00498979
What this trial is testing

Sodium Stibogluconate and IFNa-2b Followed By CDDP, VLB and DTIC Treating Pts.With Advanced Melanoma or Other Cancers

Who this might be right for
Stage IV Melanoma
Case Comprehensive Cancer Center 22
Large-scale testing (Phase 3)Study completedNCT01227889
What this trial is testing

A Study Comparing GSK2118436 to Dacarbazine (DTIC) in Previously Untreated Subjects With BRAF Mutation Positive Advanced (Stage III) or Metastatic (Stage IV) Melanoma

Who this might be right for
Cancer
GlaxoSmithKline 251
Testing effectiveness (Phase 2)Study completedNCT00327600
What this trial is testing

Safety and Efficacy Trial of Imexon Plus DTIC in Advanced Malignant Melanoma

Who this might be right for
Malignant Melanoma
AmpliMed Corporation 68
Large-scale testing (Phase 3)Study completedNCT00038558
What this trial is testing

Prophylactic Use of Filgrastim SD/01 in Patients With Hodgkin's Disease Receiving ABVD Chemotherapy

Who this might be right for
Hodgkin Disease
M.D. Anderson Cancer Center 25
Large-scale testing (Phase 3)Study completedNCT01343277
What this trial is testing

Trabectedin or Dacarbazine for the Treatment of Patients With Advanced Liposarcoma or Leiomyosarcoma

Who this might be right for
Advanced Liposarcoma or Leiomyosarcoma
Janssen Research & Development, LLC 579
Not applicableStudy completedNCT07120217
What this trial is testing

Breast Cancer Risk Investigation in Grown-up Hodgkin Lymphoma Patients Treated With MBVD. Multicenter Retrospective Study on ≥200 Adult Female HL Patients Treated With ≥1 MBVD Cycle (NPLD, Bleomycin, Vinblastine, Dacarbazine). It Investigates Breast Cancer Incidence Post-treatment.

Who this might be right for
Hodgkin DiseaseBreast CancerLiposomal Doxorubicin
Federico II University 200
Testing effectiveness (Phase 2)Ended earlyNCT01055522
What this trial is testing

Clinical Study Phase II of L19IL2 in Combination With Dacarbazine in Patients With Metastatic Melanoma

Who this might be right for
Metastatic Melanoma
Philogen S.p.A. 102
Large-scale testing (Phase 3)Study completedNCT00864253
What this trial is testing

A Trial of ABI-007 Versus Dacarbazine in Previously Untreated Patients With Metastatic Malignant Melanoma

Who this might be right for
Malignant Melanoma
Celgene 529
Testing effectiveness (Phase 2)UnknownNCT02501551
What this trial is testing

Regorafenib, C-kit Mutated Malignant Melanoma, 2nd Line Therapy

Who this might be right for
Melanoma
Yonsei University 36
Testing effectiveness (Phase 2)Study completedNCT01476410
What this trial is testing

Brentuximab Vedotin and Combination Chemotherapy in Treating Older Patients With Previously Untreated Stage II-IV Hodgkin Lymphoma

Who this might be right for
Adult Lymphocyte Depletion Hodgkin LymphomaAdult Lymphocyte Predominant Hodgkin LymphomaAdult Mixed Cellularity Hodgkin Lymphoma+4 more
Northwestern University 49
Testing effectiveness (Phase 2)UnknownNCT03279601
What this trial is testing

Study to Compare Capecitabine Combined With Dacarbazine(CAPDTIC) Versus Capecitabine Combined Temozolomide(CAPTEM) in Advanced and Metastatic Gastrointestinal Pancreatic and Esophageal Neuroendocrine Tumor

Who this might be right for
Neuroendocrine Tumors
Peking University 148
Testing effectiveness (Phase 2)UnknownNCT03095079
What this trial is testing

Rh-endostatin in Combination With Dacarbazine and Cisplatin as the First Line Therapy for Metastatic Melanoma

Who this might be right for
Melanoma
Peking University Cancer Hospital & Institute 70
Testing effectiveness (Phase 2)Study completedNCT01551459
What this trial is testing

A Phase II Study of Sunitinib Versus Dacarbazine in the Treatment of Patients With Metastatic Uveal Melanoma

Who this might be right for
Metastatic Uveal Melanoma
The Clatterbridge Cancer Centre NHS Foundation Trust 124
Testing effectiveness (Phase 2)Study completedNCT01835145
What this trial is testing

Cabozantinib-S-Malate Compared With Temozolomide or Dacarbazine in Treating Patients With Metastatic Melanoma of the Eye That Cannot Be Removed by Surgery

Who this might be right for
Recurrent Uveal MelanomaStage III Uveal Melanoma AJCC v7Stage IIIA Uveal Melanoma AJCC v7+3 more
National Cancer Institute (NCI) 47
Next Page